Jens Bjørheim
Chief Tech/Sci/R&D Officer bij ULTIMOVACS ASA
Profiel
Jens Bjørheim is currently the Chief Medical Officer at Ultimovacs ASA. Previously, he worked as the Medical Director at Pronova BioPharma ASA from 2006 to 2008 and as the Senior Medical Director-Oncology at AstraZeneca A from 2013 to 2016.
He holds two doctorate degrees, one from the University of Oslo in 1999 and another from the same university in 2003.
Actieve functies van Jens Bjørheim
Bedrijven | Functie | Begin |
---|---|---|
ULTIMOVACS ASA | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Jens Bjørheim
Bedrijven | Functie | Einde |
---|---|---|
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | 01-01-2016 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Chief Tech/Sci/R&D Officer | 01-01-2008 |
Opleiding van Jens Bjørheim
University of Oslo | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ULTIMOVACS ASA | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Health Technology |